Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Type 2 immunity in the brain and brain borders. | Cell Mol Immunol | 2023 | 37429945 | PubTator, text mining | PubMed |
| Inflammatory and tolerogenic myeloid cells determine outcome following human allergen challenge. | J Exp Med | 2023 | 37428185 | PubTator, text mining | PubMed |
| Functionalized nanoparticles crossing the brain-blood barrier to target glioma cells. | PeerJ | 2023 | 37426416 | PubTator, text mining | PubMed |
| Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments. | J Transl Med | 2023 | 37420216 | PubTator, text mining | PubMed |
| CAR-NK cell therapy for glioblastoma: what to do next? | Front Oncol | 2023 | 37404752 | PubTator, text mining | PubMed |
| Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies. | Biomark Res | 2023 | 37403182 | PubTator, text mining | PubMed |
| Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies. | J Immunother Cancer | 2023 | 37399356 | PubTator, text mining | PubMed |
| Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy. | J Immunother Cancer | 2023 | 37399355 | PubTator, text mining | PubMed |
| CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gap. | Front Oncol | 2023 | 37397356 | PubTator, text mining | PubMed |
| Synthetic Cell-Based Immunotherapies for Neurologic Diseases. | Neurol Neuroimmunol Neuroinflamm | 2023 | 37385738 | PubTator, text mining | PubMed |
| Chitinase 3-Like-1 Expression Is Upregulated Under Inflammatory Conditions in Human Oral Epithelial Cells. | Kurume Med J | 2023 | 37380444 | PubTator, text mining | PubMed |
| Natural Products for the Immunotherapy of Glioma. | Nutrients | 2023 | 37375698 | PubTator, text mining | PubMed |
| Terpinen-4-ol Induces Ferroptosis of Glioma Cells via Downregulating JUN Proto-Oncogene. | Molecules | 2023 | 37375197 | PubTator, text mining | PubMed |
| JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus. | Genes (Basel) | 2023 | 37372319 | PubTator, text mining | PubMed |
| Updates in Glioblastoma Immunotherapy: An Overview of the Current Clinical and Translational Scenario. | Biomedicines | 2023 | 37371615 | PubTator, text mining | PubMed |
| Interdependencies of the Neuronal, Immune and Tumor Microenvironment in Gliomas. | Cancers (Basel) | 2023 | 37345193 | PubTator, text mining | PubMed |
| Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide. | Cancers (Basel) | 2023 | 37345109 | PubTator, text mining | PubMed |
| Neutrophil-Related Gene Expression Signatures in Idiopathic Pulmonary Fibrosis: Implications for Disease Characteristic and Identification of Diagnostic Hub Genes. | J Inflamm Res | 2023 | 37337515 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma. | Neuro Oncol | 2023 | 37335916 | PubTator, text mining | PubMed |
| The probiotic-induced disregulation of immune-related genes in colon cells and relation with colorectal cancer. | Cell Mol Biol (Noisy-le-grand) | 2023 | 37329550 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=18